The IOTOD (Improving Outcomes in the Treatment of Opioid Dependence) summer webinar took place on 3rd September, exploring practical solutions to engage high-risk opioid use disorder (OUD) patients.  

The free educational event was hosted by our CME division, PCM Scientific, who worked closely with leading experts to develop the agenda. 

The 60-minute session, IOTOD Summer Webinar: Reach. Reconnect. Retain: Solutions for engaging high-risk opioid-use disorder (OUD) patients, was led by Dr Steve Brinksman, GP and Clinical Director of Addiction Professionals, and Medical Director at Cranstoun Birmingham, together with Mr Danny Ahmed, Nurse Prescriber, Clinical Director at Cranstoun, Clinical Partner at Foundations, and Senior Clinician at Addiction Professionals Birmingham. 

The programme addressed why patients may be lost to treatment, the importance of psychosocial support for dependent opioid users, the relative advantages of opioid replacement therapies, and how best to match patients to appropriate treatment. Practical approaches to re-engaging refractory-to-treatment patients were also explored. 

The webinar proved a great success, attracting over 200 live attendees from across the UK and Europe. Participants included addiction specialists, GPs, hospital pharmacists, nurses, pain specialists, pharmacists, and other healthcare professionals seeking to enhance their management of opioid-dependent patients.

The event was promoted through Cogora’s media brands to our community of healthcare professionals across the UK and Europe – including addiction specialists, pain specialists, GPs, primary care nurses, psychiatrists, and community pharmacists.

Feedback from delegates has been overwhelmingly positive: 

• 96% rated the quality of the webinar as excellent or good 

• 98% reported feeling more confident in their knowledge of why patients disengage from treatment 

• 99% reported greater confidence in methods to re-engage patients 

The IOTOD Summer Webinar is now available to watch on-demand on the IOTOD website. 

This IOTOD webinar is supported by grant funding from Camurus and Hospital Healthcare Europe. The educational programme is run at arm’s length from the financial supporters, and all content is created by the faculty. No funder has had input into the content of the materials or presentations used in the educational programme. PCM Scientific is the medical education company acting as scientific secretariat and webinar organiser. 

We are pleased to announce the upcoming IOTOD (Improving Outcomes in the Treatment of Opioid Dependence) Summer webinar, ‘Reach. Reconnect. Retain: Solutions for Engaging High-Risk OUD Patients,’ will take place online on Wednesday 3rd September.

This 60-minute IOTOD Summer webinar will be led by leading experts Dr Steve Brinksman, Clinical Director of SMMGP and Medical Director for Cranstoun, and Mr Daniel Ahmed, Clinical Director for Cranstoun, Clinical Partner at Foundations, and Senior Clinician at Addictions Professionals.

Developed by our CME division, PCM Scientific, this free live event will explore the reasons why some patients become refractory to opioid use disorder treatment, and whether specific patient populations may be more prone to treatment resistance.

Our expert speakers will also outline practical strategies for re-engaging these hard-to-reach patients, sharing real-world examples of how to reconnect them with addiction therapy – without repeating previously ineffective treatments. The session will conclude with a live Q&A.

The IOTOD Summer webinar is suitable for both primary and secondary care clinicians seeking to enhance the care and management of patients with opioid dependency.

The event will be promoted through Cogora’s media brands to our community of healthcare professionals across the UK and Europe – including addiction specialists, pain specialists, GPs, primary care nurses, psychiatrists, and community pharmacists.

This follows the success of our IOTOD Winter Webinar, which is available to watch free on-demand on the IOTOD website.

Improving Outcomes in the Treatment of Opioid Dependence (IOTOD) is an educational initiative that aims to advance opioid dependence healthcare through free online resources, including live events, on-demand webinars, and e-learning modules.

This independent educational activity is supported by grant funding from Camurus and Hospital Healthcare Europe. The educational programme is run at arm’s length from the financial supporters, and all content is created by the faculty. No funder has had input into the content of the materials or presentations used in the educational programme. PCM Scientific is the medical education company acting as scientific secretariat and webinar organiser.

IOTOD (Improving Outcomes in the Treatment of Opioid Dependence) education has launched a new e-learning module, ‘Getting the most out of treatment – induction, maintenance, and transitioning/switching’.

This free, IOTOD e-learning module is designed with an expert faculty to aid HCPs in optimising opioid dependence treatment for individual patients, with an understanding of which formulations may be most suitable, why monitoring is recommended, and how to set up each patient for success.

On completion of this module, participants will be able to:

• Summarise the current landscape of opioid dependence and recognise where progress needs to be made to improve care, particularly for highly stigmatised groups
• Compare the pharmacokinetic and pharmacologic properties of the available opioid agonist therapies to determine their suitability for different patient profiles 
• Explain the benefit of antagonist and adjunct therapies for detoxification regimes 
• Formulate a treatment plan that combines pharmacological agents and psychosocial support and apply it to an individual patient

A pre- and post-learning assessment is included to support to learning experience and to determine the user’s knowledge gain. So far, the average increase in knowledge post module has been 16%.

The module is being promoted via our media brands, to our community of primary and secondary care HCPs across the UK and Europe, including addiction specialists, pain specialists, GPs, primary care nurses, psychiatrists, and community pharmacists.  

This is the second module to be released from IOTOD, the first focusing on an ‘Introduction to Opioid Dependence and Treatment – A Global Escalating Challenge’.

IOTOD is an educational initiative that aims to improve opioid dependence healthcare through a variety of programmes. Our expert-created e-learning courses are easy-to-digest modules that feature essential foundation knowledge for the best practice management of opioid dependence.

It brings together HCPs from across the globe to share and discuss best practice in the field of opioid dependence. Providing a variety of live and online educational interventions, IOTOD has evolved into a diverse, multiplatform initiative driving change worldwide in the understanding and treatment of opioid dependence. IOTOD also supports harm reduction efforts, overdose prevention strategies and Hepatitis C elimination.

The e-learning module is supported by grant funding from Camurus. The educational programme is run at arm’s length from the financial supporters and all content is created by the faculty. No funder has had input into the content of the materials or presentations used in the educational programme. PCM Scientific is the medical education company acting as scientific secretariat and organiser. 

IOTOD (Improving Outcomes in the Treatment of Opioid Dependence) education has launched its first CME eLearning module, ‘Introduction to Opioid Dependence and Treatment – A Global Escalating Challenge’.

This free, IOTOD e-learning module is designed with an expert faculty to raise awareness for opioid dependence and provide healthcare professionals with an understanding of how this chronic, relapsing disorder can be best managed via individualised treatment. It offers evidence-based insights and practical tools for understanding the complexities of opioid addiction, including risk factors, intervention methods, and a comprehensive overview of treatment options.

The pilot has been launched in English while the French, Spanish and German variants are being finalised with their country experts. A pre- and post-learning assessment is included in the module to support to learning experience and to determine the user’s knowledge gain.

The module is being promoted via our media brands, to our community of primary and secondary care HCPs across the UK and Europe, including addiction specialists, pain specialists, GPs, primary care nurses, psychiatrists, and community pharmacists.  

This e-learning module follows the success of regular live and on-demand webinars, most recently the Spring / Summer webinar in May 2024, which is now available to watch on-demand.

IOTOD is an educational initiative that aims to improve opioid dependence healthcare through a variety of programmes. Our expert-created e-learning courses are easy-to-digest modules that feature essential foundation knowledge for the best practice management of opioid dependence. This includes the principles of quality care, and evidence-based guidance for the appropriate selection and application of pharmacotherapies. They are designed to prepare for and complement learning provided by other on-demand IOTOD education resources to improve the provision of quality, individualised care for opioid-dependent patients.

It brings together HCPs from across the globe to share and discuss best practice in the field of opioid dependence. Providing a variety of live and online educational interventions, IOTOD has evolved into a diverse, multiplatform initiative driving change worldwide in the understanding and treatment of opioid dependence. IOTOD also supports harm reduction efforts, overdose prevention strategies and Hepatitis C elimination.

The IOTOD e-learning module ‘Introduction to Opioid Dependence and Treatment – A Global Escalating Challenge’ is supported by grant funding from Camurus. The educational programme is run at arm’s length from the financial supporters and all content is created by the faculty. No funder has had input into the content of the materials or presentations used in the educational programme. PCM Scientific is the medical education company acting as scientific secretariat and organiser.